Indian News


pharma 032317 03jul20 Today's Daily Dose brings you news about BioLife Solutions' preliminary second-quarter revenue estimate; Immunomedics' immediate catalyst; Interpace Biosciences' stock price spike; MEI Pharma discontinuing Pracinostat trial in AML patients due to lack of efficacy and disappointing outcome from Regeneron/Sanofi's study evaluating Kevzara in COVID-19 patients.

stockmarkets jan22 02jul20 What's moving these stocks in the pre-market today?

pfizer july02 Today's Daily Dose brings you news about Pfizer/BioNTech's COVID-19 vaccine trial results; Blueprint's submission of Pralsetinib NDA; reverse merger of MedAvail with MYOS; Liminal BioSciences' efforts to fight the ongoing pandemic and upsized public offering of AdaptHealth.

akero july01 Today's Daily Dose brings you news about promising histological data from Akero's phase II NASH study; positive results of Inovio's phase I clinical trial of COVID-19 vaccine candidate INO-4800; Zynerba's Fragile X Syndrome trial results; Chiasma's stock offering; update on Alterity's phase I Multiple System Atrophy trial and disappointing results of Oncocyte's DetermaDx liquid biopsy test.

Follow RTT